Bd announces first pharma-sponsored clinical trial using bd libertas™ wearable injector technology for biologic drugs

Franklin lakes, n.j. , july 23, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the bd libertas™ wearable injector for subcutaneous delivery of complex biologics.
BDX Ratings Summary
BDX Quant Ranking